Natera and Alliance for Clinical Trials in Oncology Activate Mid-Stage Trial in Urothelial Cancer

Natera and Alliance for Clinical Trials in Oncology Mid-Stage Trial

The activation of a mid-stage trial in urothelial cancer by Natera and the Alliance for Clinical Trials in Oncology is a notable step in oncology research.

Collaborative Effort

The collaboration seeks to evaluate the effectiveness and safety of novel therapies for urothelial cancer, highlighting a dedication to advancing cancer treatment.

• Assessment of treatment outcomes
• Focus on patient safety

This milestone underscores the commitment of both organizations to driving progress in cancer research and enhancing patient care.